Novel stem cell therapy to treat central retinal vein occlusion
Go back to Newsroom
Novel stem cell therapy to treat central retinal vein occlusion
Development of cerebral lateralization in children exposed to fetal antiseizure medications: A prospective cohort study at age 6 years
Go back to Resources
Development of cerebral lateralization in children exposed to fetal antiseizure medications: A prospective cohort study at age 6 years
Authors:
Journal:
PMID:
Keywords:
Abstract:
Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity
Go back to Resources
Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity
Authors:
Journal:
PMID:
Keywords:
Abstract:
Interaction of identity and beliefs with genetic literacy
Go back to Resources
Interaction of identity and beliefs with genetic literacy
Authors:
Journal:
PMID:
Keywords:
Abstract:
Mental health challenges associated with sickle cell disease and strategies to address them: Reflections from a community input panel
Go back to Resources
Mental health challenges associated with sickle cell disease and strategies to address them: Reflections from a community input panel
Authors:
Journal:
PMID:
Keywords:
Abstract:
FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
Go back to Newsroom
FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
Go back to Newsroom
The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature
Go back to Resources
The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature
Authors:
Volume:
Pagination:
Issue:
Journal:
PMID:
Keywords:
Abstract:
Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease
Go back to Resources
Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease
Authors:
Volume:
Issue:
Journal:
PMID:
Keywords:
Abstract:
Emmes Appoints Matt Bond as CFO
Go back to Newsroom
Emmes Appoints Matt Bond as CFO
Emmes Appoints Matt Bond as CFO
Reportedly, Matt Bond’s expertise in mergers and acquisitions (M&A) and his track record with successful private-equity-backed enterprises are expected to be valuable assets in Emmes’ growth and diversification strategy.
US-based Clinical Research Organisation (CRO) Emmes has named Matt Bond as its Chief Financial Officer (CFO), succeeding former CFO Brian Hochheimer.
Go back to Newsroom
Reportedly, Matt Bond’s expertise in mergers and acquisitions (M&A) and his track record with successful private-equity-backed enterprises are expected to be valuable assets in Emmes’ growth and diversification strategy.
US-based Clinical Research Organisation (CRO) Emmes has named Matt Bond as its Chief Financial Officer (CFO), succeeding former CFO Brian Hochheimer.
US-Based Emmes Acquires VaxTRIALS
Go back to Newsroom
US-Based Emmes Acquires VaxTRIALS
US-Based Emmes Acquires VaxTRIALS
This strategic acquisition is part of Emmes’ broader objective to expand its global presence beyond its existing operations in North America, Europe, and Asia into the Latin American market. The move is expected to strengthen Emmes’ expertise in one of its core research focus areas: vaccines and infectious diseases.
US-based Clinical Research Organisation (CRO) Emmes has acquired VaxTRIALS, a specialised Clinical Research Organisation headquartered in Panama City.
Go back to Newsroom
This strategic acquisition is part of Emmes’ broader objective to expand its global presence beyond its existing operations in North America, Europe, and Asia into the Latin American market. The move is expected to strengthen Emmes’ expertise in one of its core research focus areas: vaccines and infectious diseases.
US-based Clinical Research Organisation (CRO) Emmes has acquired VaxTRIALS, a specialised Clinical Research Organisation headquartered in Panama City.